{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:21:34Z","timestamp":1790752894694,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["SYS2018005"],"award-info":[{"award-number":["SYS2018005"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Wet age-related macular degeneration, which is characterized by choroidal neovascularization (CNV) and induces obvious vision loss. Vascular endothelial growth factor (VEGF) family member VEGF-A (also named as VEGF) and its receptor VEGFR2 contribute to the pathogenesis of CNV. Choroidal endothelial cells (CECs) secret C\u2013C motif chemokine ligand 2 (CCL2), which attracts macrophages to CNV lesion and promotes macrophage M1 polarization. Accordingly, infiltrating macrophages secret inflammatory cytokines to promote CNV. In vivo, intravitreal injection of fruquintinib (HMPL-013), an antitumor neovascularization drug, alleviated mouse CNV formation without obvious ocular toxicity. Meanwhile, HMPL-013 inhibited VEGF\/VEGFR2 binding in CECs and macrophages, as well as macrophage M1 polarization. In vitro, noncontact coculture of human choroidal vascular endothelial cells (HCVECs) and macrophages under hypoxia conditions was established. HMPL-013 downregulated VEGF\/VEGFR2\/phosphoinositide-3-kinase\/protein kinase B (AKT)\/nuclear factor kappa B pathway and CCL2 secretion in HCVECs, as well as VEGF\/VEGFR2-induced macrophage M1 polarization under hypoxia condition. In addition, HMPL-013 inhibited HCEVC derived CCL2-induced macrophage migration and M1 polarization, along with macrophage M1 polarization-induced HCVECs proliferation, migration, and tube formation. Altogether, HMPL-013 alleviated CNV formation might via breaking detrimental cross talk between CECs and macrophages.<\/jats:p>","DOI":"10.1038\/s41419-020-03222-1","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T12:02:31Z","timestamp":1606478551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fruquintinib inhibits VEGF\/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiaojuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-4446","authenticated-orcid":false,"given":"Wangrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-0222","authenticated-orcid":false,"given":"Manhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"3222_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"3222_CR2","first-page":"169","volume":"6","author":"J Li","year":"2013","unstructured":"Li, J., Zhang, H., Sun, P., Gu, F. & Liu, Z. L. Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients. Int J. Ophthalmol. 6, 169\u2013173 (2013).","journal-title":"Int J. Ophthalmol."},{"key":"3222_CR3","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/01.wnr.0000133071.00786.a4","volume":"15","author":"W Eichler","year":"2004","unstructured":"Eichler, W., Yafai, Y., Wiedemann, P. & Reichenbach, A. Angiogenesis-related factors derived from retinal glial (Muller) cells in hypoxia. Neuroreport 15, 1633\u20131637 (2004).","journal-title":"Neuroreport"},{"key":"3222_CR4","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1096\/fj.201700336R","volume":"31","author":"CH Liu","year":"2017","unstructured":"Liu, C. H., Wang, Z., Sun, Y. & Chen, J. Animal models of ocular angiogenesis: from development to pathologies. FASEB J. 31, 4665\u20134681 (2017).","journal-title":"FASEB J."},{"key":"3222_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.15252\/emmm.201606561","volume":"9","author":"HD Basavarajappa","year":"2017","unstructured":"Basavarajappa, H. D. et al. Ferrochelatase is a therapeutic target for ocular neovascularization. EMBO Mol. Med. 9, 786\u2013801 (2017).","journal-title":"EMBO Mol. Med."},{"key":"3222_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.exer.2010.06.019","volume":"91","author":"L Gu","year":"2010","unstructured":"Gu, L., Chen, H., Tuo, J., Gao, X. & Chen, L. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA\/VEGFR2 or non-specific siRNA. Exp. Eye Res. 91, 433\u2013439 (2010).","journal-title":"Exp. Eye Res."},{"key":"3222_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cyto.2015.06.019","volume":"76","author":"H Zhang","year":"2015","unstructured":"Zhang, H., He, S., Spee, C., Ishikawa, K. & Hinton, D. R. SIRT1 mediated inhibition of VEGF\/VEGFR2 signaling by Resveratrol and its relevance to choroidal neovascularization. Cytokine 76, 549\u2013552 (2015).","journal-title":"Cytokine"},{"key":"3222_CR8","doi-asserted-by":"crossref","unstructured":"Long, D. et al. VEGF\/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models. JCI Insight 3, e120231 (2018).","DOI":"10.1172\/jci.insight.120231"},{"key":"3222_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/eye.2008.206","volume":"23","author":"JM Skeie","year":"2009","unstructured":"Skeie, J. M. & Mullins, R. F. Macrophages in neovascular age-related macular degeneration: friends or foes? Eye 23, 747\u2013755 (2009).","journal-title":"Eye"},{"key":"3222_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1440-1827.2011.02695.x","volume":"61","author":"X Cao","year":"2011","unstructured":"Cao, X. et al. Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol. Int. 61, 528\u2013535 (2011).","journal-title":"Pathol. Int."},{"key":"3222_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/imm.12571","volume":"147","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y. et al. Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization. Immunology 147, 414\u2013428 (2016).","journal-title":"Immunology"},{"key":"3222_CR12","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1167\/iovs.06-1085","volume":"48","author":"K Yamada","year":"2007","unstructured":"Yamada, K., Sakurai, E., Itaya, M., Yamasaki, S. & Ogura, Y. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. Investig. Ophthalmol. Vis. Sci. 48, 1839\u20131843 (2007).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"3222_CR13","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1007\/s00125-012-2710-2","volume":"55","author":"Y Nio","year":"2012","unstructured":"Nio, Y. et al. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice. Diabetologia 55, 3350\u20133358 (2012).","journal-title":"Diabetologia"},{"key":"3222_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.2018.7855","volume":"319","author":"J Li","year":"2018","unstructured":"Li, J. et al. Effect of fruquintinib vs placebo on overall survival in patients with previously treated metastatic colorectal cancer: the fresco randomized clinical trial. JAMA 319, 2486\u20132496 (2018).","journal-title":"JAMA"},{"key":"3222_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s40265-018-0998-z","volume":"78","author":"M Shirley","year":"2018","unstructured":"Shirley, M. Fruquintinib: first global approval. Drugs 78, 1757\u20131761 (2018).","journal-title":"Drugs"},{"key":"3222_CR16","doi-asserted-by":"publisher","first-page":"OCT86","DOI":"10.1167\/iovs.15-18891","volume":"57","author":"RS Shah","year":"2016","unstructured":"Shah, R. S. et al. Visible-light optical coherence tomography angiography for monitoring laser-induced choroidal neovascularization in mice. Investig. Ophthalmol. Vis. Sci. 57, OCT86\u2013OCT95 (2016).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"3222_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00280-017-3394-6","volume":"80","author":"S Zhou","year":"2017","unstructured":"Zhou, S. et al. A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [(14)C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers. Cancer Chemother. Pharm. 80, 563\u2013573 (2017).","journal-title":"Cancer Chemother. Pharm."},{"key":"3222_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/ceo.13712","volume":"48","author":"RS Phagura","year":"2020","unstructured":"Phagura, R. S., Suo, E. M. & Razavi, H. Choroidal neovascular membrane secondary to subfoveal leukemic infiltrate. Clin. Exp. Ophthalmol. 48, 520\u2013523 (2020).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"3222_CR19","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1167\/iovs.05-0855","volume":"47","author":"HJ Zambarakji","year":"2006","unstructured":"Zambarakji, H. J. et al. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 47, 2623\u20132631 (2006).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"3222_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jop.2016.0153","volume":"33","author":"J Guo","year":"2017","unstructured":"Guo, J., Luo, X., Liang, J., Xiao, M. & Sun, X. Antiangiogenic effects of doxazosin on experimental choroidal neovascularization in mice. J. Ocul. Pharm. Ther. 33, 50\u201356 (2017).","journal-title":"J. Ocul. Pharm. Ther."},{"key":"3222_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052394","volume":"8","author":"A Franceschini","year":"2013","unstructured":"Franceschini, A. et al. TNFalpha levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS ONE 8, e52394 (2013).","journal-title":"PLoS ONE"},{"key":"3222_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7837-3_1","volume":"1784","author":"A Kelly","year":"2018","unstructured":"Kelly, A., Grabiec, A. M. & Travis, M. A. Culture of human monocyte-derived macrophages. Methods Mol. Biol. 1784, 1\u201311 (2018).","journal-title":"Methods Mol. Biol."},{"key":"3222_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2011.08.002","volume":"218","author":"N Wang","year":"2011","unstructured":"Wang, N. et al. Overexpression of CREG attenuates atherosclerotic endothelium apoptosis via VEGF\/PI3K\/AKT pathway. Atherosclerosis 218, 543\u2013551 (2011).","journal-title":"Atherosclerosis"},{"key":"3222_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.taap.2013.07.014","volume":"272","author":"HA Omar","year":"2013","unstructured":"Omar, H. A. et al. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-kappaB and MAPK signaling pathways. Toxicol. Appl. Pharm. 272, 616\u2013624 (2013).","journal-title":"Toxicol. Appl. Pharm."},{"key":"3222_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","volume":"98","author":"RL Avery","year":"2014","unstructured":"Avery, R. L. et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br. J. Ophthalmol. 98, 1636\u20131641 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"3222_CR26","first-page":"2311","volume":"9","author":"X Lu","year":"2015","unstructured":"Lu, X. & Sun, X. Profile of conbercept in the treatment of neovascular age-related macular degeneration. Drug Des. Dev. Ther. 9, 2311\u20132320 (2015).","journal-title":"Drug Des. Dev. Ther."},{"key":"3222_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30503-5","volume":"19","author":"TK Burki","year":"2018","unstructured":"Burki, T. K. Fruquintinib for previously treated metastatic colorectal cancer. Lancet Oncol. 19, e388 (2018).","journal-title":"Lancet Oncol."},{"key":"3222_CR28","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1200\/JCO.2017.76.7145","volume":"36","author":"S Lu","year":"2018","unstructured":"Lu, S. et al. Randomized, double-blind, placebo-controlled, multicenter phase ii study of fruquintinib after two prior chemotherapy regimens in chinese patients with advanced nonsquamous nonsmall-cell lung cancer. J. Clin. Oncol. 36, 1207\u20131217 (2018).","journal-title":"J. Clin. Oncol."},{"key":"3222_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/17512433.2019.1630272","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen, Z. & Jiang, L. The clinical application of fruquintinib on colorectal cancer. Expert Rev. Clin. Pharm. 12, 713\u2013721 (2019).","journal-title":"Expert Rev. Clin. Pharm."},{"key":"3222_CR30","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1167\/iovs.17-21416","volume":"58","author":"KL Kim","year":"2017","unstructured":"Kim, K. L. & Suh, W. Apatinib, an inhibitor of vascular endothelial growth factor receptor 2, suppresses pathologic ocular neovascularization in mice. Investig. Ophthalmol. Vis. Sci. 58, 3592\u20133599 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"3222_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/jop.2014.0148","volume":"31","author":"T Zhao","year":"2015","unstructured":"Zhao, T. et al. Vascular endothelial growth factor receptor 2 antibody, BC001, attenuates laser-induced choroidal neovascularization in rhesus monkeys (Macaca mulatta). J. Ocul. Pharm. Ther. 31, 611\u2013616 (2015).","journal-title":"J. Ocul. Pharm. Ther."},{"key":"3222_CR32","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1167\/iovs.10-6737","volume":"52","author":"D Tomida","year":"2011","unstructured":"Tomida, D. et al. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Investig. Ophthalmol. Vis. Sci. 52, 3193\u20133199 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"3222_CR33","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.3892\/mmr.2017.6491","volume":"15","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization. Mol. Med. Rep. 15, 3949\u20133956 (2017).","journal-title":"Mol. Med. Rep."},{"key":"3222_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1189\/jlb.0902436","volume":"74","author":"C Tsutsumi","year":"2003","unstructured":"Tsutsumi, C. et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J. Leukoc. Biol. 74, 25\u201332 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"3222_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072935","volume":"8","author":"J Liu","year":"2013","unstructured":"Liu, J. et al. Myeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in mice. PLoS ONE 8, e72935 (2013).","journal-title":"PLoS ONE"},{"key":"3222_CR36","doi-asserted-by":"crossref","unstructured":"Xu, Y. et al. Melatonin attenuates choroidal neovascularization by regulating macrophage\/microglia polarization via inhibition of RhoA\/ROCK signaling pathway. J. Pineal. Res. 69, e12660 (2020).","DOI":"10.1111\/jpi.12660"},{"key":"3222_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094313","volume":"9","author":"TA Krause","year":"2014","unstructured":"Krause, T. A., Alex, A. F., Engel, D. R., Kurts, C. & Eter, N. VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization. PLoS ONE 9, e94313 (2014).","journal-title":"PLoS ONE"},{"key":"3222_CR38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jnutbio.2014.05.015","volume":"25","author":"N Nagai","year":"2014","unstructured":"Nagai, N., Kubota, S., Tsubota, K. & Ozawa, Y. Resveratrol prevents the development of choroidal neovascularization by modulating AMP-activated protein kinase in macrophages and other cell types. J. Nutr. Biochem. 25, 1218\u20131225 (2014).","journal-title":"J. Nutr. Biochem."},{"key":"3222_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep30933","volume":"6","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. Macrophage polarization in experimental and clinical choroidal neovascularization. Sci. Rep. 6, 30933 (2016).","journal-title":"Sci. Rep."},{"key":"3222_CR40","doi-asserted-by":"publisher","first-page":"872","DOI":"10.4161\/cbt.12.10.17672","volume":"12","author":"C Li","year":"2011","unstructured":"Li, C., Liu, B., Dai, Z. & Tao, Y. Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC). Cancer Biol. Ther. 12, 872\u2013880 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"3222_CR41","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2337\/diabetes.48.5.1131","volume":"48","author":"T Marumo","year":"1999","unstructured":"Marumo, T., Schini-Kerth, V. B. & Busse, R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131\u20131137 (1999).","journal-title":"Diabetes"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03222-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:57:21Z","timestamp":1670255841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03222-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03222-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1016"}}